These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6235230)

  • 1. The level of DNA interstrand crosslinking in bone marrow parallels the extent of myelosuppression in mice treated with four chloroethylnitrosoureas.
    Bedford P; Berger MR; Eisenbrand G; Schmähl D
    J Cancer Res Clin Oncol; 1984; 108(1):141-7. PubMed ID: 6235230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between DNA damage and the inhibition of stem cells in murine bone marrow after single and repeated administration of BCNU and HECNU.
    Berger MR; Henne T; Bedford P
    J Cancer Res Clin Oncol; 1985; 110(3):185-90. PubMed ID: 4077917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA damage and repair in the bone marrow of rats treated with four chloroethylnitrosoureas.
    Bedford P; Eisenbrand G
    Cancer Res; 1984 Feb; 44(2):514-8. PubMed ID: 6229329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitivity of human and murine hematopoietic precursor cells to 2-[3-(2-chloroethyl)-3-nitrosoureido]-D-glucopyranose and 1,3-bis(2-chloroethyl)-1-nitrosourea.
    Schein PS; Bull JM; Doukas D; Hoth D
    Cancer Res; 1978 Feb; 38(2):257-60. PubMed ID: 620400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical structure of carbamoylating groups and their relationship to bone marrow toxicity and antiglioma activity of bifunctionally alkylating and carbamoylating nitrosoureas.
    Ali-Osman F; Giblin J; Berger M; Murphy MJ; Rosenblum ML
    Cancer Res; 1985 Sep; 45(9):4185-91. PubMed ID: 2411398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effects of chlorozotocin and BCNU on hematopoietic precursor cells.
    Horikoshi A; Smith R; Murphy MJ
    Chemotherapy; 1983; 29(2):135-44. PubMed ID: 6220871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An analysis of 1-(2-chloroethyl)-1-nitrosourea activity at the cellular level.
    Weinkam RJ; Dolan ME
    J Med Chem; 1983 Nov; 26(11):1656-9. PubMed ID: 6226795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological and biochemical properties of 1-(2-chloroethyl)-3-(beta-D-glucopyranosyl)-1-nitrosourea (NSC D 254157), a nitrosourea with reduced bone marrow toxicity.
    Fox PA; Panasci LC; Schein PS
    Cancer Res; 1977 Mar; 37(3):783-7. PubMed ID: 138478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chlorozotocin. Mechanism of reduced bone marrow toxicity in mice.
    Panasci LC; Green D; Schein PS
    J Clin Invest; 1979 Oct; 64(4):1103-11. PubMed ID: 158033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative studies on the antitumor activity and the bone marrow toxicity of 1-(beta-D-glucopyranosyl)-3-(2-chloroethyl)-3-nitrosourea and 2-(3-(2-chloroethyl)-3-nitrosoureido)-D-glucopyranose.
    Aoshima M; Sakurai Y
    Gan; 1977 Apr; 68(2):247-50. PubMed ID: 892299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chlorozotocin, 2-(3-(2-chloroethyl)-3-nitrosoureido)-D-glucopyranose, an antitumor agent with modified bone marrow toxicity.
    Anderson T; McMenamin MG; Schein PS
    Cancer Res; 1975 Mar; 35(3):761-5. PubMed ID: 123170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific DNA repair mechanisms may protect some human tumor cells from DNA interstrand crosslinking by chloroethylnitrosoureas but not from crosslinking by other anti-tumor alkylating agents.
    Gibson NW; Zlotogorski C; Erickson LC
    Carcinogenesis; 1985 Mar; 6(3):445-50. PubMed ID: 3978757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitrosourea-misonidazole combination chemotherapy: effect on KHT sarcomas, marrow stem cells and gut.
    Mulcahy RT; Siemann DW; Sutherland RM
    Br J Cancer; 1982 Jun; 45(6):835-42. PubMed ID: 6212075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of cell cycle position on the survival of 9L cells treated with nitrosoureas that alkylate, cross-link, and carbamoylate.
    Linfoot PA; Gray JW; Dean PN; Marton LJ; Deen DF
    Cancer Res; 1986 May; 46(5):2402-6. PubMed ID: 3697983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of 1,3-bis(2-chloroethyl)-1-nitrosourea-induced severe immunodeficiency by transduction of murine long-lived hemopoietic progenitor cells using O6-methylguanine DNA methyltransferase complementary DNA.
    Maze R; Kapur R; Kelley MR; Hansen WK; Oh SY; Williams DA
    J Immunol; 1997 Jan; 158(2):1006-13. PubMed ID: 8993023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Examination of four newly synthesized 2-chloroethylnitrosoureas in comparison with BCNU, CCNU, MeCCNU, chlorozotocin and hydroxyethyl-CNU in preterminal rat leukemia L 5222.
    Zeller WJ; Eisenbrand G; Fiebig HH
    J Cancer Res Clin Oncol; 1979 Sep; 95(1):43-9. PubMed ID: 159309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repair of DNA alkylation induced in L1210 leukemia and murine bone marrow by three chloroethylnitrosoureas.
    Ahlgren JD; Green DC; Tew KD; Schein PS
    Cancer Res; 1982 Jul; 42(7):2605-8. PubMed ID: 6211225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of DNA damage in various tissues, myelosuppression and serum levels of transaminases and bilirubin in tumor-bearing female Sprague-Dawley rats treated with 1-(2-hydroxyethyl)-3-(2-chloroethyl)-3-nitrosourea (HECNU).
    Henne T; Berger MR
    J Cancer Res Clin Oncol; 1986; 111(1):75-8. PubMed ID: 3949853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticancer nitrosoureas: investigations on antineoplastic, toxic and neoplastic activities.
    Eisenbrand G
    IARC Sci Publ; 1984; (57):695-708. PubMed ID: 6533062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrovirus-mediated expression of a DNA repair protein in bone marrow protects hematopoietic cells from nitrosourea-induced toxicity in vitro and in vivo.
    Moritz T; Mackay W; Glassner BJ; Williams DA; Samson L
    Cancer Res; 1995 Jun; 55(12):2608-14. PubMed ID: 7780976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.